Risultati della ricerca - Jaeseong Oh

A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects di Xu Jiang, Kyung-Sang Yu, Dong Hyuk Nam, Jaeseong Oh

Connect to this object online.

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration di Sungyeun Bae, Ki Young Huh, Jaeseong Oh, Kyung-Sang Yu, Anhye Kim

Connect to this object online.

Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease di Xuanyou Jin, Jaeseong Oh, Joo-Youn Cho, SeungHwan Lee, Su-jin Rhee

Connect to this object online.

Key Considerations for Phase 2 or 3 Clinical Study Design of Anti-Inflammatory Agent for COVID-19 Treatment di Yewon Park, Joo Young Na, Joo-Youn Cho, Jaeseong Oh, Su-jin Rhee

Connect to this object online.

Pharmacokinetic evaluation of radiolabeled intraocular anti‐CLEC14a antibody in preclinical animal species and application in humans di Sohyun Park, Youn Woo Lee, Jaeseong Oh, Su Jin Kim, Sukmook Lee, Ho‐Young Lee

Connect to this object online.

Semimechanistic pharmacokinetic-pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy di Soyoung Lee, Kyung Taek Hong, In‐Jin Jang, Kyung‐Sang Yu, Hyoung Jin Kang, Jaeseong Oh

Connect to this object online.

Dose-dependent reduction of lymphocyte count and heart rate after multiple administration of LC51-0255, a novel sphingosine-1-phosphate receptor 1 modulator, in healthy subjects di Inyoung Hwang, Sang Won Lee, Jaeseong Oh, SeungHwan Lee, In-Jin Jang, Kyung-Sang Yu

Connect to this object online.

Single‐dose of LC51‐0255, a selective S1P1 receptor modulator, showed dose‐dependent and reversible reduction of absolute lymphocyte count in humans di Sang Won Lee, Inyoung Hwang, Jaeseong Oh, SeungHwan Lee, In‐Jin Jang, Kyung‐Sang Yu

Connect to this object online.

Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers di Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung‐Sang Yu, In‐Jin Jang, Jaeseong Oh

Connect to this object online.

Endogenous metabolic markers for predicting the activity of dihydropyrimidine dehydrogenase di Jihyun Kang, Andrew HyoungJin Kim, Inseung Jeon, Jaeseong Oh, In‐Jin Jang, SeungHwan Lee, Joo‐Youn Cho

Connect to this object online.

The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects di Sejung Hwang, Soyoung Lee, Eunwoo Kim, Inyoung Hwang, Joo‐Youn Cho, Jae‐Yong Chung, In‐Jin Jang, Jaeseong Oh

Connect to this object online.

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects di JungJin Oh, Eunsol Yang, In-Jin Jang, Hyejung Lee, Hokyun Yoo, Jae-Yong Chung, SeungHwan Lee, Jaeseong Oh

Connect to this object online.

Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms di Ki Young Huh, Woo Kyung Chung, Jiyeon Park, SeungHwan Lee, Min‐Gul Kim, Jaeseong Oh, Kyung‐Sang Yu

Connect to this object online.

Effects of meal type on the bioavailability of vutiglabridin, a novel anti‐obesity agent, in healthy subjects di Heejae Won, Deok Yong Yoon, Sangmi Lee, Joo‐Youn Cho, Jaeseong Oh, In‐Jin Jang, Sang‐Ku Yoo, Kyung‐Sang Yu

Connect to this object online.

Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor‐Mediated Recycling of HL2351, a Novel Hybrid Fc‐Fused Interleukin‐1 Receptor Antagonist, to Optimize Dosage R... di Lien Ngo, Jaeseong Oh, Anhye Kim, Hyun‐moon Back, Won‐ho Kang, Jung‐woo Chae, Hwi‐yeol Yun, Howard Lee

Connect to this object online.

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects di Min Young Park, Sungyeun Bae, Jung A Heo, Mihee Park, YuKyung Kim, Jumi Han, In‐Jin Jang, Kyung‐Sang Yu, Jaeseong Oh

Connect to this object online.

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study di Joo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, SeungHwan Lee, Kyung‐Sang Yu, In‐Jin Jang, Sang‐Ku Yoo, Youngah Kim, Jaeseong Oh

Connect to this object online.

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses di Sang-Hwan Ji, Sang-Hwan Ji, Ki Young Huh, Ki Young Huh, Jaeseong Oh, Jaeseong Oh, Hee-Jeong Jeong, Hee-Jeong Jeong, Young-Eun Jang, Young-Eun Jang, Eun-Hee Kim, Eun-Hee Kim, Ji-Hyun Lee, Ji-Hyun Lee, Jin-Tae Kim, Jin-Tae Kim, Hee-Soo Kim, Hee-Soo Kim

Connect to this object online.

Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis di Sang‐Hwan Ji, Ki Young Huh, Jaeseong Oh, Hee‐Jeong Jeong, Young‐Eun Jang, Eun‐Hee Kim, Ji‐Hyun Lee, Jin‐Tae Kim, Hee‐Soo Kim

Connect to this object online.

Continuous versus intermittent infusion of human antithrombin III concentrate in the immediate postoperative period after liver transplantation di Bo Rim Kim, Leerang Lim, YoungRok Choi, Nam‐Joon Yi, Kwang‐Woong Lee, Kyung‐Suk Suh, Kyung‐Sang Yu, Jin Young Sohn, Raewon Jeong, Jaeseong Oh, Ho Geol Ryu

Connect to this object online.